Topical Corticosteroid vs. Leukotriene Antagonist Therapy in Recurrent  Nasal Polyps: A case control: study with Biochemical Inflammatory Markers

Ghulam Dastgir Khan, Ahmed Hassan, Muhammad Tahir Shah, Anees Ur Rehman, Damish Arsalan, Javeria Sarfraz

Topical Corticosteroid vs. Leukotriene Antagonist Therapy in Recurrent Nasal Polyps: A case control: study with Biochemical Inflammatory Markers

Authors

Ghulam Dastgir Khan, Ahmed Hassan, Muhammad Tahir Shah, Anees Ur Rehman, Damish Arsalan, Javeria Sarfraz

Keywords:

recurrent nasal polyps; topical corticosteroid; leukotriene antagonist; eosinophil cationic protein; interleukin-5.

Abstract

Recurrent nasal polyps (RNP) impose substantial morbidity and recurrence despite surgicalintervention. While topical corticosteroids (TCS) are frontline therapy, leukotriene antagonists

References

Kim, S. J., & Park, J. H. (2022). Serum alkaline phosphatase as a diagnostic biomarker in biliary obstruction: A meta-analysis. Hepatology Research, 52(5), 409–419. https://doi.org/10.1111/hepr.13794

Downloads

Published

2025-07-19

How to Cite

Ghulam Dastgir Khan, Ahmed Hassan, Muhammad Tahir Shah, Anees Ur Rehman, Damish Arsalan, Javeria Sarfraz. (2025). Topical Corticosteroid vs. Leukotriene Antagonist Therapy in Recurrent Nasal Polyps: A case control: study with Biochemical Inflammatory Markers. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 497–504. Retrieved from https://www.ijprt.org/index.php/pub/article/view/735